Reduced Muscular Carnosine in Proximal Myotonic Myopathy—A Pilot 1H‐MRS Study
ABSTRACT Objective Myotonic dystrophy type 2 (proximal myotonic myopathy, PROMM) is a progressive multisystem disorder with muscular symptoms (proximal weakness, pain, myotonia) and systemic manifestations such as diabetes mellitus, cataracts, and cardiac arrhythmias.
Alexander Gussew +11 more
wiley +1 more source
Dynamical description and analytical study of traveling wave solutions for generalized Benjamin-Ono equation. [PDF]
Hassaballa AA +5 more
europepmc +1 more source
Laboratory work on identification of linear dynamic systems using a digital oscilloscope PV6503
Nataliya Korovyats’ka
openalex +1 more source
Acoustic Measures Capture Speech Dysfunction in Spinocerebellar Ataxia
ABSTRACT Objective Spinocerebellar ataxias (SCA) are hereditary cerebellar degenerative disorders with a common feature of dysarthria, involving impaired phonatory and articulatory control of speech, thereby affecting social communication. In this study, we investigated whether acoustic measures could objectively measure speech dysfunction and identify
Zena Fadel +5 more
wiley +1 more source
Sensitivity characteristics of the Hirota-Maccari system in nonlinear materials. [PDF]
Khater MMA, Alfalqi SH, Vokhmintsev A.
europepmc +1 more source
Glymphatic Dysfunction Reflects Post‐Concussion Symptoms: Changes Within 1 Month and After 3 Months
ABSTRACT Objective Mild traumatic brain injury (mTBI) may alter glymphatic function; however, its progression and variability remain obscure. This study examined glymphatic function following mTBI within 1 month and after 3 months post‐injury to determine whether variations in glymphatic function are associated with post‐traumatic symptom severity ...
Eunkyung Kim +3 more
wiley +1 more source
Delayed dynamics and detoxification in nutrient-phytoplankto-by-product systems: mechanisms driving bloom stability and oscillations. [PDF]
Baghel RS, Verma S, Khatri N.
europepmc +1 more source
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin +11 more
wiley +1 more source
β-Fractional [Formula: see text]-dimensional generalized KP model: nonlinear dynamical behaviors, analytical wave structures, bifurcation, and sensitivity analysis. [PDF]
Demirbilek U +4 more
europepmc +1 more source

